Q1 2026 ALK-Abello A/S Earnings Call Transcript
/-
Hello everyone, and welcome to this presentation of ALK's Q1 results. Thank you all for joining us. Let's turn to slide number too with an introduction to the speakers and the agenda. My name is Per Plotnikov, I'm Head of Investment Relations, and with me are CEO, Peter Halling; and CFO Claus Steensen Sølje. Peter and Claus will walk you through the highlights, markets, product trends and financial. And after a strategic update where we'll focus on peanut allergy, our respiratory tablets and the neffy rollout, we will turn to the full-year outlook.
As usual, we will end the call with a Q&A session. And to get started, I'll hand you over to Peter on slide three. Please go ahead, Peter.
/- -
Thank you, Per.
Thank you all for taking the time to listen to this call. ALK had a very solid start to the year with revenue and earnings
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
